ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 690

$963K Total Retail Price of All Prescriptions

Rank: 65 out of 690

651 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 1,231 1,112 160 1 3
FUROSEMIDE 1,039 927 129 2 5
AMLODIPINE BESYLATE 866 809 109 3 2
GABAPENTIN 734 604 102 4 9
POTASSIUM CHLORIDE 732 696 101 5 10
LISINOPRIL 698 622 92 6 4
LEVOTHYROXINE SODIUM 654 547 85 7 6
HYDROCHLOROTHIAZIDE 628 546 85 8 13
PRAVASTATIN SODIUM 602 550 76 9 11
METFORMIN HCL 565 452 74 10 8
MELOXICAM 553 472 84 11 14
METOPROLOL TARTRATE 540 491 79 12 23
WARFARIN SODIUM 495 419 70 13 22
SIMVASTATIN 475 447 65 14 7
CLOPIDOGREL 473 455 54 15 16
ATORVASTATIN CALCIUM 406 350 50 16 12
METOPROLOL SUCCINATE 366 323 54 17 17
DONEPEZIL HCL 345 345 49 18 27
TRAMADOL HCL 342 317 90 19 21
ZOLPIDEM TARTRATE 337 271 57 20 24
CITALOPRAM HBR 333 296 53 21 19
HYDROCODONE-ACETAMINOPHEN 305 186 66 S3 22 1
SERTRALINE HCL 297 261 46 23 28
CLONIDINE HCL 277 221 34 24 38
RANITIDINE HCL 265 233 44 25 30
LOSARTAN POTASSIUM 265 225 38 25 25
CARVEDILOL 245 234 36 27 15
GLIMEPIRIDE 242 208 33 28 33
FLUTICASONE PROPIONATE 224 186 63 29 46
QUETIAPINE FUMARATE 223 187 26 A 30 54
ATENOLOL 208 176 26 31 31
NEXIUM 203 121 26 32 26
TAMSULOSIN HCL 201 181 32 33 37
NAMENDA 201 201 18 33 29
TRIAMTERENE-HCTZ 192 181 24 35 47
ROPINIROLE HCL 191 169 24 36 86
AMITRIPTYLINE HCL 185 101 21 R 37 53
ALLOPURINOL 178 173* 25 38 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 140 22 39 18
DIOVAN 171 166* 16 40 42
OXYBUTYNIN CHLORIDE 153 127 23 41 134
MECLIZINE HCL 152 147* 33 42 81
PANTOPRAZOLE SODIUM 138 113 35 43 34
ISOSORBIDE MONONITRATE ER 138 133* 20 43 61
BENAZEPRIL HCL 133 111 13 45 68
MIRTAZAPINE 133 128* 20 45 59
PROPRANOLOL HCL 132 120 14 47 124
ZETIA 126 113 12 48 88
CRESTOR 125 101 15 49 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 99 64 50 73
PREDNISONE 122 107 40 51 55
PAROXETINE HCL 122 106 13 51 69
ESCITALOPRAM OXALATE 114 90 15 53 51
DIVALPROEX SODIUM 114 93 11 53 102
DIGOX 113 113 19 55 87
NIFEDIPINE ER 111 106* 19 56 100
LEVEMIR 109 <11 <11 57 129
KLOR-CON M20 108 82 18 58 76
DIGOXIN 106 101* 18 59 167
LORAZEPAM 102 97* 26 B 60 41
METFORMIN HCL ER 101 84 15 61 65
LYRICA 101 <11 <11 61 57
GLYBURIDE 101 69 13 R 61 118
ENALAPRIL MALEATE 100 89 15 64 80
PREMARIN 97 64 12 R 65 153
CIPROFLOXACIN HCL 97 81 63 65 50
METOCLOPRAMIDE HCL 94 89* 14 67 121
AMOXICILLIN 93 71 77 68 103
LEVETIRACETAM 93 <11 <11 68 114
MONTELUKAST SODIUM 92 87* 13 70 44
BYSTOLIC 90 <11 <11 71 89
CEPHALEXIN 90 85* 62 71 83
ALENDRONATE SODIUM 88 77 13 73 75
COLCRYS 87 76 17 74 118
DILTIAZEM 24HR CD 87 87 14 74 176
HYDRALAZINE HCL 84 79* 12 76 73
CELEBREX 82 82 13 77 99
RISPERIDONE 82 <11 <11 A 77 72
LANTUS 79 57 17 79 70
SYNTHROID 78 73* 16 80 52
GLIPIZIDE 77 49 12 81 78
TRAZODONE HCL 77 54 13 81 36
DILTIAZEM ER 77 72* 11 81 137
EVISTA 71 <11 <11 84 125
CYCLOBENZAPRINE HCL 70 41 18 R 85 60
CARBIDOPA-LEVODOPA 69 <11 <11 86 133
PROMETHAZINE HCL 68 41 29 R 87 90
LEVEMIR FLEXPEN 66 <11 <11 88 163
PHENYTOIN SODIUM EXTENDED 65 <11 <11 89 98
AZITHROMYCIN 65 48 48 89 49
GLIPIZIDE ER 65 <11 <11 89 115
CYMBALTA 65 <11 <11 89 45
FAMOTIDINE* 63 <11 <11 93 67
AVODART 60 <11 <11 94 195
BACLOFEN 60 <11 <11 94 113
AMOX TR-POTASSIUM CLAVULANATE 60 44 46 94 117
CALCITONIN-SALMON 59 <11 <11 97 322
VANCOMYCIN HCL* 58 <11 <11 98 420
POLYETHYLENE GLYCOL 3350 58 53* 21 98 62
AMIODARONE HCL 57 <11 <11 100 139
ALPRAZOLAM 56 51* 11 B 101 20
NOVOLIN R 56 51* 16 101 174
SPIRONOLACTONE 56 <11 <11 101 63
VENLAFAXINE HCL ER 55 <11 <11 104 91
CARBAMAZEPINE 54 <11 <11 105 196
FINASTERIDE 53 <11 <11 106 172
LOSARTAN-HYDROCHLOROTHIAZIDE 52 <11 <11 107 43
TRANDOLAPRIL 52 <11 <11 107 437
TERAZOSIN HCL 52 <11 <11 107 157
IBUPROFEN 52 <11 <11 107 104
OXYBUTYNIN CHLORIDE ER 52 <11 <11 107 158
DETROL LA 51 <11 <11 112 142
LOVASTATIN 50 <11 <11 113 40
GEMFIBROZIL 50 <11 <11 113 140
RAMIPRIL 50 <11 <11 113 96
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.